Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled time : 12:20 save search
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Published: 2024-04-07 (Crawled : 12:20) - prnewswire.com
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
| Email alert
Add to watchlist
disease risk women heart
Immunic Presents Data From Phase 1b Clinical Trial of IMU-856 in Celiac Disease at the United European Gastroenterology Week 2023
Published: 2023-10-15 (Crawled : 12:20) - prnewswire.com
IMUX | $1.24 0.0% 130K
|
Health Technology
| Email alert
Add to watchlist
imu-856 disease week trial
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants
Published: 2023-07-11 (Crawled : 12:20) - globenewswire.com
PPRUF | News | $345.01 1.47% 37.56% 1.6K
|
Consumer Non-Durables
|
| O: 3.26%
H: 0.0%
C: -0.57%
PPRUY | News | $34.9595 3.46% -0.11% 390K
|
Manufacturing
|
| O: 1.02%
H: 0.9%
C: 0.75%
PCVX | $60.3 -0.95% -1.05% 700K
|
Health Technology
|
| O: -2.77%
H: 2.2%
C: 0.65%
STRO | $3.47 -6.72% -7.2% 730K
|
Health Technology
|
| O: -1.47%
H: 1.71%
C: 0.64%
vax-24 disease pneumococcal ongoing study
BioVie to Present Data Showing How NE3107 Potentially Regulates DNA Methylation of Specific Genes in a Manner Highly Correlated to Observed Improvements in Cognition and Biomarkers of Disease
Published: 2023-07-10 (Crawled : 12:20) - globenewswire.com
BIVI | $0.5054 2.77% 2.13% 830K
|
Health Technology
|
| O: 0.23%
H: 6.97%
C: 5.17%
ne3107 disease dna biomarkers
Sangamo Therapeutics and Voyager Therapeutics Enter License Agreement for Epigenetic Regulation Treatment of Prion Disease
Published: 2023-06-29 (Crawled : 12:20) - ir.voyagertherapeutics.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 0.34%
H: 3.31%
C: -3.46%
SGMO | News | $0.493 -5.36% -6.07% 1.2M
|
Health Technology
|
| O: 0.0%
H: 5.0%
C: 4.17%
disease license treatment therapeutics agreement
Horizon Therapeutics plc Announces Positive Topline Data from Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Active Thyroid Eye Disease (TED)
Published: 2023-06-22 (Crawled : 12:20) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.25%
H: 0.75%
C: 0.04%
tepezza disease active japan positive treatment thyroid topline eye trial therapeutics
Chinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy Volunteers and New Insights into the Role of Failed Repair in Chronic Kidney Disease at the 60th European Renal Association (ERA) Congress
Published: 2023-06-17 (Crawled : 12:20) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
| Email alert
Add to watchlist
chk-336 disease kidney association renal trial therapeutics
NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO
Published: 2023-05-30 (Crawled : 12:20) - biospace.com/
NEO | $14.03 -0.92% -0.93% 540K
|
Health Services
|
| O: 0.17%
H: 2.24%
C: -1.62%
disease asco impact molecular
Inhibikase Therapeutics Announces Dosing of First Patient in its Phase 2 '201' Clinical Trial of IkT-148009 to Treat Parkinson's Disease
Published: 2023-05-16 (Crawled : 12:20) - biospace.com/
IKT | $1.87 18.35% 3.66% 62K
|
Health Technology
|
| O: -2.03%
H: 3.62%
C: 0.71%
disease ikt-148009 parkinson's trial therapeutics
Cassava Sciences Completes Patient Dosing in a Randomized Controlled Trial of Simufilam in Alzheimer’s Disease
Published: 2023-05-11 (Crawled : 12:20) - globenewswire.com
SAVA M | $20.74 0.93% 0.96% 450K
|
Health Technology
|
| O: 0.0%
H: 6.03%
C: 3.18%
disease alzheimer’s sciences trial
Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023
Published: 2023-05-08 (Crawled : 12:20) - biospace.com/
BHC | $8.56 0.35% 0.12% 2M
|
Health Technology
|
| O: 0.94%
H: 2.55%
C: 1.78%
disease presentation pharmaceuticals
AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®
Published: 2023-05-06 (Crawled : 12:20) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
| Email alert
Add to watchlist
week disease abbvie
Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual Meeting
Published: 2023-04-28 (Crawled : 12:20) - globenewswire.com
PCSA | $1.62 1.25% 4.19% 36K
|
Producer Manufacturing
|
| O: 1.74%
H: 16.0%
C: 12.5%
pcs1285 disease pharmaceuticals meeting week results
Silence Therapeutics to Present at Guggenheim’s Genomic Medicines and Rare Disease Days
Published: 2023-03-29 (Crawled : 12:20) - biospace.com/
SLN | $22.27 -1.07% -0.81% 110K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: -21.66%
rare disease genomic therapeutics
Entrada Therapeutics to Participate in Guggenheim Genomic Medicines and Rare Disease Conference
Published: 2023-03-29 (Crawled : 12:20) - biospace.com/
TRDA | $12.43 -3.57% -2.79% 39K
|
Professional, Scientific, and T...
|
| O: -0.47%
H: 3.81%
C: -0.4%
rare conference disease genomic therapeutics
Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
Published: 2023-03-27 (Crawled : 12:20) - biospace.com/
PASG | News | $1.24 0.81% 3.15% 39K
|
Health Technology
|
| O: -3.85%
H: 4.0%
C: 3.0%
rare disease genomic
Aclaris Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
Published: 2023-03-27 (Crawled : 12:20) - biospace.com/
ACRS | $1.17 -4.1% -2.95% 1.2M
|
Health Technology
|
| O: 0.37%
H: 3.02%
C: 1.24%
conference disease therapeutics
Vaccinex, Inc. to Present at the 2023 AAIC Advancements: Immunity ConferenceMarch 24th presentation to highlight learnings related to pepinemab’s mechanism of action in both Huntington’s Disease and Alzheimer’s Disease
Published: 2023-03-23 (Crawled : 12:20) - biospace.com/
VCNX | $5.005 0.84% -2.76% 3.3K
|
Health Technology
|
| O: -3.01%
H: 2.54%
C: -1.03%
disease alzheimer’s presentation
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference
Published: 2023-03-22 (Crawled : 12:20) - biospace.com/
EQ | $1.79 4.07% 4.44% 110K
|
Health Technology
|
| O: 4.98%
H: 2.89%
C: -6.18%
conference disease
Cognition Therapeutics to Present Proteomic Biomarker Analyses from Clinical Studies of CT1812 in Patients with Alzheimer’s Disease at AD/PD 2023
Published: 2023-03-21 (Crawled : 12:20) - globenewswire.com
CGTX | News | $1.99 -0.5% 0.0% 110K
|
|
| O: 0.0%
H: 11.76%
C: 4.12%
ct1812 disease biomarker alzheimer’s therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.